Anton Gopka

Anton Gopka — general partner at ATEM capital, and also Dean of Faculty of Technological Management and Innovations of ITMO University. Professional interests and competencies: investments in Life Sciences, IPO, M&A, leadership within the BOD of start-ups.

Participated on the boards of directors: Tobira Therapeutics (NASDAQ: TBRA) (sold to Allergan with total payments up to $1.Marinus Pharmaceuticals (NASDAQ: MRNS), Neothetics (NASDAQ: NEOT), CoDa Therapeutics, Tragara Pharmaceuticals, NovaDigm Therapeutics, Atea Pharmaceuticals, ReVision Optics (observer), Syndax Pharmaceuticals (NASDAQ: SNDX) (observer), etc. Anton is a member of the American National Association of Corporate Directors (NACD) and a member of the advisory committee of the National Cancer Institute.